|
EXCELSIOR HEALTH LTD
REGISTERED NUMBER: 10257312
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 JUNE 2021
Notes
The legal form of the entity is a private company limited by share capital, registered in England and Wales and the registered address is situated at Unit 4, 40:40 Link, Mill End Road, High Wycombe, HP12 4BG.
Average number of employees
|
The average monthly number of employees, including directors, during the year was 1 (2020 - 1).
Directors' benefits: advances, credits and guarantees
|
The director advanced interest free loans to the company that is repayable on demand. The amounts outstanding as at the balance sheet date is £NIL (2020- £22,731). The company granted drawdown facilities to members of key management personnel for a maximum amount of £50,000 at any one point in time. The principal terms are that the amounts outstanding is repayable on demand and subject to the outstanding balance due from any individual exceeding £10,000 at any one point in time the company will charge interest on the average balance at the end of each financial year by applying HM Revenue and Customs average official rate of interest on beneficial loans in force during the same accounting period. The company reserves the rights to apply any salaries, bonuses, dividends, expenses or any such amounts of whatever nature due to the directors by the company as repayment of the outstanding balances on their current account. Included in debtors amounts falling due within one year is an amount of £2,791 (2020 – £NIL) outstanding from members of key management personnel.
Director's confirmations
The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 April 2022.
................................................
S Hundal
|
|
|
|
